ISV-305
Phase 3Completed 0 views this week 0 watching⚡ Active
Interest: 40/100
40
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 24
Phase 35
ApprovedIndication / Disease
Inflammation and Pain Associated With Cataract Surgery
Conditions
Inflammation and Pain Associated With Cataract Surgery
Trial Timeline
Jan 3, 2018 → Nov 18, 2019
NCT ID
NCT03192150About ISV-305
ISV-305 is a phase 3 stage product being developed by Sun Pharmaceutical for Inflammation and Pain Associated With Cataract Surgery. The current trial status is completed. This product is registered under clinical trial identifier NCT03192150. Target conditions include Inflammation and Pain Associated With Cataract Surgery.
What happened to similar drugs?
2 of 14 similar drugs in Inflammation and Pain Associated With Cataract Surgery were approved
Approved (2) Terminated (2) Active (10)
Hype Score Breakdown
Clinical
17
Activity
8
Company
15
Novelty
0
Community
0
Clinical Trials (3)
| NCT ID | Phase | Status |
|---|---|---|
| NCT01543490 | Phase 3 | Completed |
| NCT03192137 | Phase 3 | Completed |
| NCT03192150 | Phase 3 | Completed |
Competing Products
20 competing products in Inflammation and Pain Associated With Cataract Surgery